
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
TriNutra’s black seed ingredient clinically supports oral microbiome, teeth and gingival health
Key takeaways
- ThymoQuin-OCare significantly improved gingival health by reducing inflammation and bleeding markers by 14% over a 28-day period.
- The ingredient boosted oral microbiome diversity in 89% of participants while promoting beneficial bacteria and suppressing harmful acid formation.
- Clinical results showed visible reductions in plaque and tartar alongside subjective reports of fresher breath and cleaner teeth.

Botanical extract innovator TriNutra highlights new human clinical research supporting its patented black seed-derived ingredient ThymoQuin-OCare for oral health support. The ingredient demonstrated benefits across plaque and tartar prevention, gingival health, and oral microbiome balance.
Building on previous research, the study found that ThymoQuin-OCare helps suppress microbial overgrowth and reduces acid formation, sustaining overall fresher breath.
“The oral microbiome plays a central role in maintaining gum health, immune function, and barrier integrity,” says Morris Zelkha, CEO of TriNutra. “We are thrilled that the research findings suggest ThymoQuin-OCare supports optimal oral hygiene and a healthier mouth.”
Effective lozenge format
Over time, gingival inflammation and oral microbiome dysbiosis can lead to acid formation and teeth demineralization, which are crucial contributors to oral health issues.

TriNutra highlights that conventional oral hygiene strategies typically focus on reducing plaque buildup and targeting harmful bacteria through brushing, flossing, and the use of antimicrobial products.
The black seed oil ingredient demonstrated benefits across plaque and tartar prevention, gingival health, and oral microbiome balance.However, the company says that recent advances in oral care have sparked growing interest in complementary approaches.
The new study tracked dental health, gingival health, and microbial shifts during supplementation. Researchers assessed ThymoQuin-OCare’s safety and effectiveness as an oral health lozenge over a 28-day period.
The clinical assessment confirmed significant changes in hard and soft oral tissues, confirming the excellent tolerability of ThymoQuin-OCare. Researchers also noted reductions in dental plaque accumulation and gingival bleeding, as the participants’ Gingival Index decreased by 14%.
Notably, 67% of participants showed measurable reductions in gingival inflammation and all participants demonstrated at least one measurable positive outcome during the study period.
Additionally, an oral microbiota analysis revealed that 89% of participants had an increase in the Shannon Diversity Index. The ingredient promoted the growth of beneficial (commensal) microflora, with no pathogenic microflora growth recorded before or after application.
Subjectively, 67–78% of participants reported fresher, longer-lasting breath, and 89% reported visible improvements in their gum appearance, tooth cleanliness, and overall oral wellness.
Oral health advances
In other research developments in oral care, scientists at New York University, US, discovered that certain harmful bacteria can travel through swallowed saliva into the pancreas, linking it to 3.5 times greater risk of developing pancreatic cancer. They concluded that practicing a diet “close to the Mediterranean diet” offers a higher chance of better gum health, with potentially lower gum disease and inflammation.
Research has also found that people with type 2 diabetes have higher tooth decay than others. Scientists explain that high blood glucose levels, or hyperglycemia, cause the migration of sugars, like glucose and fructose, to saliva — enabling cavity-causing bacteria to grow.










